(Q63832899)

English

Nilotinib in the Treatment of Systemic Sclerosis

clinical trial

Statements

Phase IIA Study of the Safety and Tolerability of the Use of Nilotinib in the Treatment of Systemic Sclerosis (English)
0 references
July 2010
0 references
July 2014
0 references
10
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit